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ABSTRACT
	 SIRT1 is a mammalian homologue of yeast longevity protein Sir2. SIRT1 deacetylates transcription factors, 
cofactors, and histones in an NAD+-dependent manner, and promotes cell survival, anti-oxidative function, and DNA 
repair. Although some studies have indicated that SIRT1 is involved in longevity, the function of SIRT1 for 
preventing aging and senescence is still unclear. In mouse embryonic fibroblasts (MEFs), we found that SIRT1 
expression decreased by aging and SIRT1 reciprocally regulated the expression level of Prl2C3, one of the prolactin-
like peptides. In young MEFs, purified Prl2C3 inhibited the growth and increased the number of senescence-
associated β galactosidase-positive cells with enlarged and flattened shapes. Moreover, immunostaining of human 
skin sections showed the expression of Prl2C3 in the basal cells of the epidermis. These results indicate that SIRT1 
negatively regulates a senescence-associated protein Prl2C3.
(Accepted October 31, 2017)
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1. Introduction
 Sirtuins are mammalian homologues of Sir2, 
which is implicated in the longevity of yeast. 
Increases in the Sir2  gene dosage promote 
longevity, whereas yeast with decreases in Sir2 
activity shows a short lifespan 1）. Of the seven 
mammalian sirtuins, SIRT1 is an NAD+-dependent 
protein deacetylase that plays crucial roles in 
metabolism, cell  survival,  oxidative stress 
reduct ion,  DNA repair  and other  ce l lular 
r e s p o n s e s  2）.  A l t h o u g h  t h e  g l o b a l  S I R T 1 
overexpression in mice does not extend their 
lifespan, decreases of glucose homeostasis, bone 
mass, wound-healing and neuro-muscular function 
are ameliorated in aged SIRT1-transgenic mice 3）. 
Brain-specific overexpression of SIRT1 promotes 
longevity in mice, resulting in approximate 10% 
increase in median lifespan 4）. Accordingly, the 
lifespan of the homozygote SIRT1-knockout mice is 
reduced 5）. Resveratrol (3,5,4'-trihydroxy-trans-
stilbene), a polyphenol found in grapes and red 
wine,  has been found to  act ivate SIRT1  6）. 
Resveratrol opposes the effects of high-calorie diets 
and extends the lifespan of mice fed with such 
diet 7）. Dietary restriction has been shown to 
prolong mean and maximum lifespan in various 
organisms 8） and induces high expression levels of 
SIRT1 9）. However, SIRT1-knockout mice do not 
show any lifespan extension through dietary 
restriction 10）. Thus, SIRT1 is closely related with 
improvement of healthy aging and longevity. 
 Because SIRT1 controls gene expression by 
deacetylation of various transcription factors, 
coactivators, corepressors, and histones 2）, we have 
hypothesized that some proteins affecting aging 
may be regulated by SIRT1 activity. Using DNA 
microarray experiments we identified Prl2C3, one 
of the prolactin-related proteins. Prl2C3 was 
induced in aged mouse embryonic fibroblasts 
(MEFs) and negatively regulated by SIRT1 activity. 
Prl2C3  was expressed in basal cells of  the 
epidermis, the expression level of which increased 
in aged persons.
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2. Materials and Methods
2. 1. Cell culture
 MEFs were isolated from ddY mice purchased 
from Sankyo Labo Service Corporation,Inc. (Tokyo, 
Japan). After the head and visceral tissues were 
removed from the embryos, the remaining bodies 
were finely chopped using a razor blade, which was 
followed by trypsinization at 37°C for 20 min. 
Tissues and cell clumps then were dissociated by 
pipetting and the cells were plated in a 10-cm 
culture dish (Passage 1). In the 3T3 protocol, cells 
were trypsinized and counted every 3 days, which 
was followed by replating of 300,000 cells 11）. MEFs 
were cultured in Dulbecco modified Eagle medium 
(DMEM; Wako) supplemented with 10% FBS at 
37°C in a humidified incubator with 5% CO2. 
C2C12, COS7, and B16F1 cells were grown at 37 ºC 
in 5% CO2 in DMEM containing 10% FBS (C2C12 
and COS7) or 5% FBS (B16F1 cells).
2. 2. siRNA transfection
 Cells were transfected with siRNA (50 nM) 
using RNAiMAX (Invitrogen) according to the 
manufacturer's instructions. Mouse SIRT1 siRNA 
(SASI_Mm01_00105675) and siRNAs for negative 
control were purchased from Sigma Genosys. 
Knockdown was confirmed by RT-PCR and 
immunoblot 48 hr after transfection.
2. 3. RNA analysis 
 Isolation of total RNA from cultured cells and 
reverse transcriptase reaction were performed as 
previously described 12）. Quantitative PCR was 
performed using GoTaq qPCR Master  Mix 
(Promega) and the following oligonucleotide 
p r i m e r s :  f o r  m o u s e  P r l 2 C 3 ,  5 ’- 
CCAACTCCAGTAAAGCATCTTCC-3’ and 5’- 
GTATCCAGGAGCATGGTTGAATCG-3’; for mouse 
18S, 5’-CGGACAGGATTGACAGATTG-3’ and 
5’-CAAATCGCTCCACCAACTAA-3’. Each sample 
was run in duplicate and the mean value was used 
to calculate the mRNA expression of the gene of 
interest and the housekeeping reference gene (18S). 
All assays were performed by the standard curve 
method  us ing  ser ia l  cDNA di lut ion .  DNA 
microarray experiments using Agilent Array were 
carried out by Hokkaido System Science Co.
2. 4. Preparation of anti-Prl2C3 polyclonal antibody
 The polyclonal antibody for mouse Prl2C3 was 
raised in rabbits against a synthetic peptide as 
previously  descr ibed  13）.  Pept ide  sequence 
corresponded to amino acid residues 187^207 
(DARIHSLYGMISCLDNDFKKV) in the C-terminal 
region of Prl2C3, which shows identical sequences 
between human and mice.
2. 5. Human tissue sections and immunohistochemistry
 All samples were collected from Japanese 
patients who underwent outpatient or inpatient 
care at Sapporo Medical University Hospital. 
Informed consent was obtained from all patients 
before collection of the specimens. Approval for this 
study was obtained from the Institutional Review 
Board of Sapporo Medical University. Paraffin 
sections (5 μm thickness) were deparaffinized with 
xylene and ethyl alcohol and then autoclaved in 0.1 
M sodium citrate, pH6.0 for antigen-activation. 
Sections were immunostained with an anti-Prl2C3 
antibody (1:500 dilution) and anti-SIRT1 antibody 
(1:500 dilution) as previously described 14）. The 
bound antibodies were labeled with Alexa Fluor 488 
or 594-conjugated goat anti-rabbit secondary 
antibody (Thermo Fisher Scientific) and examined 
by confocal microscopy (Radiance 2100, Bio-Rad). 
Nuclei were stained by Hoechst33342. Images were 
analyzed using ImageJ software (National 
Institutes of Health).
2. 6. Western blotting
 Samples from cells were prepared for immunoblot 
analysis as previously described 12）. The antibodies 
used for immunoblot analysis were anti-p19 (1:100, 
Santa Cruz), β-actin (1:10000, Wako Pure Chemical), 
anti-GAPDH (1:10000, Sigma Aldrich), and anti-α
-tubulin (1:10000, Sigma Aldrich).
2. 7. Plasmid construction, expression and purification 
of Prl2C3
 The coding region of mouse Prl2C3 cDNA was 
obtained by RT-PCR using oligonucleotide primers 
of 5’-AAGGTATCCATGCTCCCTTCTTCG-3’, and 
-5’-AACTCGAGGCAGTTATCTATTTT-3’, and 
inserted into the pIRES-hrGFP plasmid. The 
FLAG-tagged Prl2C3 plasmid was transfected into 
COS7 cells with the ViaFect Transfection Reagent 
(Promega). Three days after transfection, the 
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culture medium was incubated with an anti-FLAG 
antibody resin at 4 °C overnight. Prl2C3-bound 
resin was collected by centrifugation and washed 
three times with 50 mM Tris HCl, pH 7.5, 1 mM 
EDTA and 150 mM NaCl. Purified Prl2C3 was 
eluted with 100 mM glycine HCl, pH 3.0 and then 
neutralized using 1 M Tris HCl, pH 8.0. The protein 
concentration was assayed by the Bradford Reagent 
(Sigma-Aldrich).
2. 8. Measurements of cellular ATP content
 Cellular ATP levels were measured by using 
the Cell Titer-Glo Luminescent Cell Viability Assay 
(Promega) according to the manufacturer's protocol, 
with an ARVO Light Luminescence Counter 
(PerkinElmer).
2. 9. SA-β-gal staining
 SA-β-gal staining was performed in MEFs 
using the Senescence Detection Kit (Biovision) 
according to the manufacturer's instructions.
2. 10. Reagents
 Resveratrol, Hoechst33342 and the anti-FLAG 
resin were from Wako Pure Chemicals. 
2. 11. Statistics
 Data  f rom at  least  three  independent 
experiments are represented as means ± S.D. 
Comparisons between two groups were made using 
the Student's t-test, Welch's t-test, and Mann-
Whitney U test.
3. Results
 To examine the role of SIRT1 in cellular 
senescence and aging, MEFs were examined. 
Proliferation of MEF cells was severely suppressed 
after 5 passages. The cell numbers of Passage 5 (P5) 
and P8 cells were almost identical, indicating that 
cells progressively became senescent after P5 
(Figure 1A). Accordingly, mRNA and protein levels 
of p19, one of the CDK inhibitors, in P8 MEFs were 
significantly increased compared with those of P2 
MEFs (Figures 1B and 1C). We compared SIRT1 
expression levels in MEFs of P2 and P8. SIRT1 
mRNA of P8 MEFs was about 60% of that of P2 
cells (Figure 1D), whereas Western blot analysis 
showed that protein levels of SIRT1 in P8 cells 
significantly decreased to less than 20% of that of 
P2 cells (Figure 1E). Immunostaining of SIRT1 also 
showed a significant decrease in the expression 
level of SIRT1 in P8 cells (Figure 1F).
 Resveratrol is an activator of SIRT1  6）. To 
identify the genes whose expression levels are 
regulated by SIRT1 activity, resveratrol and SIRT1-
siRNA were used. RNAs from C2C12 cells treated 
with 100 μM resveratrol for 12 hr were compared 
with those of control cells by DNA microarray. 
RNAs from SIRT1-knockdown C2C12 cells were 
also compared with those from control cells. The 
expression levels of genes up-regulated more than 
2-fold or down-regulated less than 0.5-fold by the 
SIRT1 activator or SIRT1-knockdown, respectively, 
were examined (data not shown). Among them, the 
expression level of Prl2C3, one of the prolactin-
related proteins, was found to increase by more 
than 10-fold in C2C12 cells with SIRT1 knockdown. 
Treatment of cells with resveratrol decreased the 
Prl2C3 expression level by about one-fourth of that 
o f  control  C2C12  ce l ls .  Importantly ,  DNA 
microarray of P2 and P8 MEFs showed that Prl2C3 
level increased by 8-fold in P8 MEF cells compared 
with that of P2 young cells.
 Quantitative RT-PCR experiments and 
Western blot analysis showed that the expression 
levels of Prl2C3 mRNA and protein increased more 
than 3-fold in P8 MEFs compared with those of P2 
cells (Figures 2A and 2B). Immunostaining also 
showed a significant increase of Prl2C3 levels in P8 
MEFs (Figure 2C). SIRT1 knockdown in MEFs 
significantly increased Prl2C3 mRNA and protein 
levels (Figures 2D, 2E, and 2F).
 To examine the function of Prl2C3, FLAG-
tagged Prl2C3 was expressed in COS7 cells. Prl2C3 
was found in the culture medium after transfection 
(data not shown). Prl2C3 was purified from a 
culture medium using an anti-FLAG antibody 
resin. Although purified Prl2C3 was liable to 
degenerate, it significantly suppressed proliferation 
of P2 MEFs (Figure 3A).
 Cell numbers significantly decreased in MEFs 
treated with purified Prl2C3, indicating that Prl2C3 
suppressed ce l l  prol i ferat ion (Figure  3A). 
Accordingly, ATP content of each well significantly 
decreased in MEF cells treated with Prl2C3 
(Figure 3A). Similar to MEFs, proliferation of 
B16F1 mouse melanoma cells was also significantly 
suppressed by Prl2C3 treatment (Figure 3B).
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Fig. 1. Decrease in SIRT1 expression level by aging in MEFs
 (A) Cumulative population doubling (PD) of MEFs plotted with passage number on the x axis and PD on the y axis. PD = log2 
(collected cell number three days after seeded)/ (seeded cell number). (B) qRT-PCR analysis for p19 on P2 and P8 MEFs. 
Results were normalized to 18s and expressed as fold change relative to P2. Significance of the difference between P2 and P8 
was determined by Student's t-test (n = 4). (C) Western blot analysis for p19 on P2 and P8 MEFs. Signal intensity was 
quantified using the ImageJ analysis software. Results were normalized to GAPDH and expressed as fold change relative to P2. 
Significance of the difference was determined by Whelch's t-test (n = 4). (D) qRT-PCR analysis for SIRT1 on P2 and P8 MEFs. 
Results were expressed as fold change relative to P2. Significance of the difference was determined by Student's t-test (n = 4). 
(E) Western blot analysis for SIRT1 on P2 and P8 MEFs. Signal intensity was quantified using the ImageJ analysis software. 
Results were normalized to β-actin and expressed as fold change relative to P2. Significance of the difference was determined 
by Mann-Whitney U test (n = 9). (F) Representative confocal images of P2 and P8 MEFs stained with SIRT1 (green) and 
Hoechst33342 (blue). SIRT1 staining intensity was quantified using the ImageJ analysis software. Significance of the difference 
was determined by Student's t-test (P2: n = 30, P8: n = 10). Scale bar, 30 μm. Statistical significance is represented by 
asterisks corresponding to *p < 0.05, **p < 0.01.
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Fig. 2. Increase in Prl2C3 expression level by aging and SIRT1-knockdown in MEFs
 (A) qRT-PCR analysis for Prl2C3 on P2 and P8 MEFs. Results were normalized to 18s and expressed as fold change relative 
to P2. Significance of the difference between P2 and P8 was determined by Whelch's t-test (n = 4). (B) Western blot analysis 
for Prl2C3 on P2 and P8 MEFs. Signal intensity was quantified using the ImageJ analysis software. Results were normalized 
to GAPDH and expressed as fold change relative to P2. Significance of the difference was determined by Student's t-test (n = 
4). (C) Representative confocal images of P2 and P8 MEFs stained with anti-Prl2C3 antibody (green) and Hoechst33342 (blue). 
Staining intensity of Prl2C3 was quantified using the ImageJ analysis software. Significance of the difference was determined 
by Mann-Whitney U test (n = 10). Scale bar, 30 μm. (D) qRT-PCR analysis of SIRT1 mRNA of P2 MEF cells treated with 
control siRNA or SIRT1-siRNA. (E) qRT-PCR analysis for Prl2C3 of P2 MEF cells treated with control siRNA or SIRT1-
siRNA. Results were normalized to 18s and expressed as fold change relative to control. Significance of the difference was 
determined by Whelch's t-test (n = 4). (F) Western blot analysis for Prl2C3 of P2 MEF cells treated with control siRNA or 
SIRT1-siRNA. Signal intensity was quantified using the ImageJ analysis software. Results were normalized to α-tubulin and 
expressed as fold change relative to control. Significance of the difference was determined by Whelch's t-test (n = 4). Statistical 
significance was represented by asterisks corresponding to *p < 0.05, **p < 0.01.
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Fig. 3. Induction of cellular senescence by Prl2C3
 (A) Representative images of Hoechst33342 staining in MEFs treated with vehicle (Control) or Prl2C3. Cells were cultured in 
the absence or presence of Prl2C3 (22 μg/ml) for 120 h. Cell number per one visual field was represented. Significance of the 
difference was determined by Welch's t-test (n = 16). ATP contents of cell lysates were expressed as fold change relative to 
control. Significance of the difference was determined by Student's t-test (n = 8). (B) Representative images of Hoechst33342 
staining in vehicle- (Control) or Prl2C3-treated B16F1 cells. Cells were cultured in the absence or presence of Prl2C3 
(22 μg/ml) for 96 h. Cell number per one visual field (control: n = 16, Prl2C3: n = 14), ATP contents (n = 8) were indicated. 
(C-E) Representative images of control and Prl2C3-treated MEF cells (C), B16F1 cells (D) and C2C12 cells (E). Cell surface 
area was quantified using the ImageJ analysis software. Results were expressed as fold change relative to control. Significance 
of the difference was determined by Mann-Whitney U test (n = 30 for MEFs and B16F1 cells, and n = 12 for C2C12 cells). 
Scale bars, 100 μm. (F) Representative images (left) of SA-β-gal staining in P2 MEFs treated with vehicle (Control) or Prl2C3 
(11 μg/ml) for 11 days. The percentage of SA-β-gal-positive cells in a visual field was analyzed (n = 10). Significance of the 
difference was determined by Mann-Whitney U test. Statistical significance is represented by asterisks corresponding to 
*p < 0.05, **p < 0.01. Scale bars, 100 μm (A, B, C, D, and F); 10 μm (E).
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 Aged MEFs were flattened and enlarged 
compared with young MEFs. Treatment of young 
P2 MEFs with Prl2C3 induced morphological 
change, and cell size were significantly increased by 
Prl2C3  in  MEFs (Figure  3C),  B16F1  ce l ls 
(F igure  3D) and C2C12  ce l l s  (F igure  3E) . 
Senescence-associated β-galactosidase (SA-β-gal) 
staining showed that Prl2C3 induced senescence of 
P2 MEFs (Figure 3F).
 To address physiological roles of Prl2C3 in 
aging, human skin sections were examined by 
immunohistochemistry. Prl2C3 was expressed in 
basal cells of epidermis (Figure 4). The intensity of 
Prl2C3 immunostaining was prominent in basal 
cells of elderly compared with those of children 
(Figure 4).
4. Discussion
 T h e  S I R T 1  p r o t e i n  l e v e l  o f  P 8  M E F s 
significantly decreased compared with that of P2 
MEFs (Figures 1E and 1F). The expression level of 
Prl2C3 increased by aging (Figures 2A, 2B, and 2C) 
and by SIRT1-knockdown in MEFs (Figures 2D, 2E, 
and 2F). Prl2C3 was identified as a senescence-
associated protein, because treatment of Prl2C3 
suppressed proliferation and enlarged cell size of 
MEFs and B16F1 (Figures 3A and 3B) and induced 
high expression levels of SA-β-gal (Figure 3F).
 Previously Prl2C3 was identified as a prolactin-
related protein and also referred to as a mitogen-
regulated protein (MRP) or proliferin (Plf) showing 
gestationally specific expression in the placenta 15）. 
It was suggested that proliferin increased the cell 
number of hematopoietic and stromal cell lines 16）, 
microvilli formation and cell proliferation of 
neuroblastoma cells  17）.  There is therefore a 
discrepancy between previous experiments and our 
own. The reason for this discrepancy is unknown. 
P r l 2 C 3  m a y  h a v e  d u a l  f u n c t i o n s  o n  c e l l 
proliferation and cellular senescence, which might 
be similar to insulin-like growth factor 1 (IGF-1). 
IGF-1 is a mediator of growth hormones. IGF-1 is 
released from the liver by growth hormones in the 
blood stream and induces cellular proliferation and 
growth. However, IGF-1 also accelerates aging and 
increases mortality in various organisms 8）. Hetero-
knockout of the IGF-1 gene increased the lifespan 
of mice by up to 65% 18）.
 We found that SIRT1 protein levels were 
severely decreased after the eighth passage of cells, 
but the mRNA level of SIRT1 was not comparable 
to the decrease of  the SIRT1  protein level 
(Figures 1D, 1E, and 1F). Accordingly, a progressive 
decline of SIRT1 protein levels but not SIRT1 
mRNA levels was found in MEFs from mouse ICR 
strains and human lung fibroblasts (IMR90) 19）. 
PPARγ, a ligand-regulated nuclear receptor, was 
shown to directly bind SIRT1 and inhibits SIRT1 
activity  20）.  Although acetylation of  PPARγ 
increased in cellular senescence, further study is 
necessary to elucidate the decrease in SIRT1 
protein levels in senescent MEFs.
 Prl2C3 flattened and enlarged MEFs, B16F1 
and C2C12  cells (Figures 3C, 3D, and 3E). 
Moreover, Prl2C3 significantly increased the 
number of SA-β-gal staining-positive P2 MEFs 
(Figure 3F). These findings indicate that Prl2C3 
induces senescence.
 We found that Prl2C3 was expressed in the 
basal cells of the human epidermis (Figure 4A). 
Previously, expression of Prl2C3 was reported in 
mouse hair follicles where Prl2C3 may participate 
in the hair follicle cycle as a growth factor and/or 
angiogenesis factor 21）. Prl2C3 might possess 
another function such as induction of the resting 
phase of the hair follicle (telogen phase of the hair 
cycle). Further studies will show the physiological 
function of Prl2C3 in skin aging.
Fig. 4.  Increase in Prl2C3 expression level of the basal cells of 
human epidermis of the elderly
 Representative images of human tissue sections of 
epidermis stained with anti-Prl2C3 antibody (green) and 
Hoechst33342 (blue). Scale bar, 100 μm.
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　SIRT1 は酵母の長寿遺伝子 Sir2 の哺乳類における









Prl2C3 タンパクは若い MEF の増殖を抑制し，老化
を示すβ-ガラクトシダーゼ陽性の MEF を増加させ，
細胞を大型で平坦な形態に変化させた．ヒトの皮膚組
織の免疫染色において，Prl2C3 は主に表皮内の基底
細胞に発現していた．これらの結果は，SIRT1 が老
関連タンパクである Prl2C3 を負に制御することを示
している．
